[Federal Register Volume 86, Number 43 (Monday, March 8, 2021)]
[Notices]
[Pages 13388-13390]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04674]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60 Day-21-1182; Docket No. CDC-2021-0016]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a reinstatement 
of a currently approved data collection titled ``Formative

[[Page 13389]]

Research to Develop HIV Social Marketing Campaigns for Healthcare 
Providers.'' The purpose of this data collection is to understand 
healthcare providers' interpretation and understanding of existing and 
emergent HIV prevention science; understand how providers use guidance 
or evidence-based approaches in their practices generally and with 
populations that have been largely overlooked (e.g., transgender 
individuals, people who inject drugs (PWID)); and to inform the 
development and/or revision of messages, concepts and materials for 
healthcare providers designed to support patient-provider communication 
about HIV testing, prevention, and care in support of the U.S. 
Department of Health and Human Services' Ending the HIV Epidemic.

DATES: CDC must receive written comments on or before May 7, 2021.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0016 by any of the following methods:
    <bullet> Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
    <bullet> Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
<a href="/cdn-cgi/l/email-protection#f29d9f90b2919691dc959d84"><span class="__cf_email__" data-cfemail="dbb4b6b99bb8bfb8f5bcb4ad">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Formative Research to Develop HIV Social Marketing Campaigns for 
Healthcare Providers (OMB Control No. 0920-1182)--Reinstatement without 
Change--National Center for HIV/AIDS, Viral Hepatitis, STD and TB 
Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    To address the HIV epidemic in the U.S., the Department of Health 
and Human Services launched Ending the HIV Epidemic: A Plan for 
America, which is a cross-agency initiative aiming to reduce new HIV 
infections in the U.S. by 90% by 2030 (CDC, 2019a). CDC's Let's Stop 
HIV Together campaign (formerly known as Act Against AIDS) is part of 
the national Ending the HIV Epidemic initiative and includes resources 
aimed at reducing HIV stigma and promoting testing, prevention, and 
treatment across the HIV care continuum.
    Within this context, CDC's Division of HIV/AIDS Prevention (DHAP) 
has, and will continue implementing various communication initiatives 
to increase healthcare providers' awareness of HIV testing-, 
prevention- and treatment-related topics; reduce new HIV infections 
among disproportionately impacted populations; and improve health 
outcomes for people living with HIV/AIDS in the US and its territories. 
Specifically, the initiatives target healthcare providers, including 
primary care, and relevant specialties such as HIV medicine and 
infectious disease, physicians, physician assistants, and nurses.
    The rounds of data collection include exploratory, message testing, 
concept testing, and materials testing. Information collected by DHAP 
will be used to assess healthcare providers' informational needs about 
topics related to HIV testing, prevention, and treatment; pre-test 
campaign-related messages, concepts, and materials; and evaluate the 
extent to which the communication initiatives are reaching the target 
audiences and providing them with trusted HIV-related information. Data 
collections will include in-depth interviews and brief surveys.
    The data gathered under this request will be summarized in reports 
prepared for CDC by its contractor, such as quarterly and annual 
reports and topline reports that summarize results from each data 
collection. It is possible that data from this project will be 
published in peer-reviewed manuscripts or presented at conferences; the 
manuscripts and conference presentations may appear on the internet. 
The total estimated annualized burden hours are 902.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
          Respondents               Form name       respondents    responses per   response (in     (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Healthcare providers..........  Study screener..           1,138               1           10/60             190
                                Web-based survey             569               1           15/60             142
                                Exploratory                   95               1               1              95
                                 Guide--Preventi
                                 on with
                                 Positives In-
                                 depth Interview.

[[Page 13390]]

 
                                Exploratory                   95               1               1              95
                                 Guide--Transgen
                                 der Health In-
                                 depth Interview.
                                Exploratory                   95               1               1              95
                                 Guide--HIV
                                 Prevention In-
                                 depth Interview.
                                Message Testing               95               1               1              95
                                 In-depth
                                 Interview Guide.
                                Concept Testing               95               1               1              95
                                 In-depth
                                 Interview Guide.
                                Materials                     95               1               1              95
                                 Testing In-
                                 depth Interview.
                               ---------------------------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             902
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-04674 Filed 3-5-21; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>